510(k) Report

FDA applicant

Suzhou Hengrui Callisyn Biomedical Co., Ltd.

Suzhou, CN1 decision2018–20180 recalls

FDA records 1 decision for Suzhou Hengrui Callisyn Biomedical Co., Ltd. (Suzhou, CN) in 2018: 1 510(k) clearance. All are in product code NAJ (Agents, Embolic, For Treatment Of Uterine…). Its devices cite 1 predicate, 0 of them its own earlier devices. No recall is linked to its devices.

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) refreshed weekly, last Nov 3, 2026

FIG. A — Illustration, cardiovascular panel, where it files most

How often FDA has decided Suzhou Hengrui Callisyn Biomedical Co., Ltd.’s devices, and how often a recall has named them.

FDA decisions per year

1in 2018

2018: 1
2018high 1 (2018) · low 0 (2019)2026

2026 so far, outlined.

Recalls per year

No recall linked to its devices since 2018.

FIG. 1 — Suzhou Hengrui Callisyn Biomedical Co., Ltd. by year, 2018–2026Sources: FDA decision databases, recall and enforcement reports · Data through Oct 25, 2026

Planning a device like Suzhou Hengrui Callisyn Biomedical…’s? A 510(k) Report ranks candidate predicates for your device by lineage, citations and recall history, with the review-time outlook.

See the 510(k) Report

Which product codes does it file in?

  • NAJAgents, Embolic, For Treatment Of Uterine Fibroids1decision

Whose devices does it build on?

Its devices cite 1 predicate; 0 are its own earlier devices. The firms it cites most:

Who builds on its devices?

Later devices cite its devices 3 times; 0 of those are its own. The firms that cite it most:

Which of its devices are cited most?

Its devices that later submissions most often claim equivalence to.

  • K173871CalliSpheres Embolic Microspheres, 8Spheres Embolic MicrospheresSuzhou Hengrui Callisyn Biomedical Co., Ltd. · 20183cite it

What has FDA decided for it lately?

  • K173871CalliSpheres Embolic Microspheres, 8Spheres Embolic MicrospheresSuzhou Hengrui Callisyn Biomedical Co., Ltd. · 2018

The one decision as Suzhou Hengrui Callisyn Biomedical Co., Ltd. →